Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Jahanshahi, M.
1991.
Psychosocial factors and depression in torticollis.
Journal of Psychosomatic Research,
Vol. 35,
Issue. 4-5,
p.
493.
Bihari, Katalin
Hill, James L.
and
Murphy, Dennis L.
1992.
Obsessive-compulsive characteristics in patients with idiopathic spasmodic torticollis.
Psychiatry Research,
Vol. 42,
Issue. 3,
p.
267.
Jahanshahi, M
and
Marsden, C D
1992.
Psychological functioning before and after treatment of torticollis with botulinum toxin..
Journal of Neurology, Neurosurgery & Psychiatry,
Vol. 55,
Issue. 3,
p.
229.
Jahanshahi, Marjan
and
Marsden, C. David
1993.
Botulinum and Tetanus Neurotoxins.
p.
591.
Medd, David Y.
1997.
Dystonia and hypnosis.
Contemporary Hypnosis,
Vol. 14,
Issue. 2,
p.
121.
Cardoso, Francisco
and
Jankovic, Joseph
1997.
DYSTONIA AND DYSKINESIA.
Psychiatric Clinics of North America,
Vol. 20,
Issue. 4,
p.
821.
Gudex, Claire M.
Hawthorne, Maurice R.
Butler, Anthony G.
and
Duffey, Philip
1998.
Effect of dystonia and botulinum toxin treatment on health‐related quality of life.
Movement Disorders,
Vol. 13,
Issue. 6,
p.
941.
Brin, Mitchell F.
and
Benabou, Reina
1999.
Cervical dystonia (torticollis).
Current Treatment Options in Neurology,
Vol. 1,
Issue. 1,
p.
33.
Papathanasiou, Ilias
MacDonald, Lea
Whurr, Renata
and
Jahanshahi, Marjan
2001.
Perceived stigma in Spasmoic Torticollis.
Movement Disorders,
Vol. 16,
Issue. 2,
p.
280.
Velickovic, Miodrag
Benabou, Reina
and
Brin, Mitchell F.
2001.
Cervical Dystonia.
Drugs,
Vol. 61,
Issue. 13,
p.
1921.
Moraru, E.
Schnider, P.
Wimmer, A.
Wenzel, T.
Birner, P.
Griengl, H.
and
Auff, E.
2002.
Relation between depression and anxiety in dystonic patients: implications for clinical management.
Depression and Anxiety,
Vol. 16,
Issue. 3,
p.
100.
Figgitt, David P.
and
Noble, Stuart
2002.
Botulinum Toxin B.
Drugs,
Vol. 62,
Issue. 4,
p.
705.
GÜNDEL, HARALD
WOLF, ANJA
XIDARA, VASSILIKI
BUSCH, RAYMONDE
LADWIG, KARL-HEINZ
JACOBI, FRANK
VON RAD, MICHAEL
and
CEBALLOS-BAUMANN, ANDRES O.
2003.
HIGH PSYCHIATRIC COMORBIDITY IN SPASMODIC TORTICOLLIS: A CONTROLLED STUDY.
The Journal of Nervous and Mental Disease,
Vol. 191,
Issue. 7,
p.
465.
Jahanshahi, Marjan
Rowe, John
and
Fuller, Rebecca
2003.
Cognitive executive function in dystonia.
Movement Disorders,
Vol. 18,
Issue. 12,
p.
1470.
Gündel, Harald
and
Ceballos-Baumann, Andres O.
2004.
Bewegungsstörungen bei Psychischen Erkrankungen.
p.
253.
Cano, Stefan J.
Hobart, Jeremy C.
Fitzpatrick, Ray
Bhatia, Kailash
Thompson, Alan J.
and
Warner, Thomas T.
2004.
Patient‐based outcomes of cervical dystonia: A review of rating scales.
Movement Disorders,
Vol. 19,
Issue. 9,
p.
1054.
Heiman, G. A.
Ottman, R.
Saunders-Pullman, R. J.
Ozelius, L. J.
Risch, N. J.
and
Bressman, S. B.
2004.
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers.
Neurology,
Vol. 63,
Issue. 4,
p.
631.
Munhoz, Renato P.
Teive, Helio A.G.
Della Coletta, Marcus V.
Germiniani, Francisco M.B.
Iwamoto, Fábio M.
Camargo, Carlos H.F.
and
Werneck, Lineu César
2005.
Frequency of obsessive and compulsive symptoms in patients with blepharospasm and hemifacial spasm.
Arquivos de Neuro-Psiquiatria,
Vol. 63,
Issue. 2a,
p.
213.
Duane, Drake D.
2005.
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers.
Neurology,
Vol. 64,
Issue. 10,
p.
1821.
Factor, Stewart A.
Molho, Eric S.
Evans, Sharon
and
Feustel, Paul J.
2005.
Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Movement Disorders,
Vol. 20,
Issue. 9,
p.
1152.